PulseAugur
中
实时 12:44:07
实体 Drug Manufacturers' Delayed Disclosure of Serious and Unexpected Adverse Events to the US Food and Drug Administration

Drug Manufacturers' Delayed Disclosure of Serious and Unexpected Adverse Events to the US Food and Drug Administration

PulseAugur coverage of Drug Manufacturers' Delayed Disclosure of Serious and Unexpected Adverse Events to the US Food and Drug Administration — every cluster mentioning Drug Manufacturers' Delayed Disclosure of Serious and Unexpected Adverse Events to the US Food and Drug Administration across labs, papers, and developer communities, ranked by signal.

Show in brief
总计 · 30天
1
90 天内 1
发布 · 30天
0
90 天内 0
论文 · 30天
0
90 天内 0
层级分布 · 90 天
主题
情绪 · 30 天

1 天有情绪数据

最近 · 第 1/1 页 · 共 1 条
  1. RESEARCH · CL_278942 ·

    特朗普政府的降低药价策略面临审查

    特朗普政府提出了旨在降低美国处方药成本的八项策略。这些提案包括增加竞争、改革回扣制度以及探索药品进口等措施。然而,这些措施的有效性尚不确定,可能面临实施和意外后果方面的挑战。